Healthcare -
Biotechnology - NASDAQ - US
$ 1.4
-1.41 %
$ 6.69 M
Market Cap
-0.14
P/E
PHIO - COST OF REVENUE
Cost of Revenue PHIO - Phio Pharmaceuticals Corp.
6.33 M
LAST VALUE
474.27%
2 YEAR CAGR
7.92%
5 YEAR CAGR
-9.74%
10 YEAR CAGR